ABSTRACT Introduction: The ongoing SARS-CoV-2 pandemic is a serious threat for the
health of immunocompromised patients. Among neutralizing antibody-based therapeutics …

Patients with inborn errors of immunity (IEI) in Argentina were encouraged to receive
licensed Sputnik, AstraZeneca, Sinopharm, Moderna, and Pfizer vaccines, even though …

Germline human heterozygous STAT1 gain‐of‐function (GOF) variants were first discovered
a common cause of chronic mucocutaneous candidiasis (CMC) in 2011. Since then …

The Coronavirus disease 2019 (COVID-19) pandemic has represented an unprecedented
challenge for humankind from health, economic, and social viewpoints. In February 2020 …

The analysis of rare cases of severe COVID-19, coupled with assessing the impact of SARS-
CoV2 infection in individuals with previously diagnosed IEI, has revealed fundamental …

Selective IgA deficiency (sIgAD) is the most common primary immunodeficiency disease
(PID), with an estimated occurrence from about 1: 3000 to even 1: 150, depending on …

To the Editor: Over the past year, the coronavirus disease 2019 (COVID-19) has resulted in
a worldwide pandemic. The disease results in a wide range of clinical presentations that …

Live-attenuated SARS-CoV-2 vaccines received relatively little attention during the COVID-
19 pandemic. Despite this, several methods of obtaining attenuated coronaviruses are …

Autosomal recessive PRKCD deficiency has previously been associated with the
development of systemic lupus erythematosus in human patients, but the mechanisms …

Background SARS-CoV-2 vaccination is recommended in patients with inborn errors of
immunity (IEIs); however, little is known about immunogenicity and safety in these patients …